Compounded GLP-1 RA drugs: An introduction to the Alliance for Pharmacy Compounding

Proponents of compounding pharmacy say it’s a necessary service that helps patients and physicians in the pursuit of good health. In this video series, Scott Brunner, CEO of the Alliance for Pharmacy Compounding, introduces the organization, explains what compounding pharmacists do, and how their work relates to primary care and the glucagon-like peptide-1 receptor agonist drugs (GLP-1 RA drugs) for diabetes and obesity, which have become pharmaceutical blockbusters.